These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 21856403)

  • 1. GMP issues for recombinant plant-derived pharmaceutical proteins.
    Fischer R; Schillberg S; Hellwig S; Twyman RM; Drossard J
    Biotechnol Adv; 2012; 30(2):434-9. PubMed ID: 21856403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant-derived vaccines and other therapeutics produced in contained systems.
    Franconi R; Demurtas OC; Massa S
    Expert Rev Vaccines; 2010 Aug; 9(8):877-92. PubMed ID: 20673011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioreactor systems for in vitro production of foreign proteins using plant cell cultures.
    Huang TK; McDonald KA
    Biotechnol Adv; 2012; 30(2):398-409. PubMed ID: 21846499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Production of recombinant proteins in suspension-cultured plant cells.
    Plasson C; Michel R; Lienard D; Saint-Jore-Dupas C; Sourrouille C; de March GG; Gomord V
    Methods Mol Biol; 2009; 483():145-61. PubMed ID: 19183898
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plant-based production of biopharmaceuticals.
    Fischer R; Stoger E; Schillberg S; Christou P; Twyman RM
    Curr Opin Plant Biol; 2004 Apr; 7(2):152-8. PubMed ID: 15003215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality assessment of recombinant proteins produced in plants.
    Medrano G; Dolan MC; Condori J; Radin DN; Cramer CL
    Methods Mol Biol; 2012; 824():535-64. PubMed ID: 22160919
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The moss bioreactor.
    Decker EL; Reski R
    Curr Opin Plant Biol; 2004 Apr; 7(2):166-70. PubMed ID: 15003217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plant-made therapeutics: an emerging platform in South Africa.
    Rybicki EP; Chikwamba R; Koch M; Rhodes JI; Groenewald JH
    Biotechnol Adv; 2012; 30(2):449-59. PubMed ID: 21839824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bench to batch: advances in plant cell culture for producing useful products.
    Weathers PJ; Towler MJ; Xu J
    Appl Microbiol Biotechnol; 2010 Feb; 85(5):1339-51. PubMed ID: 19956945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contained and high-level production of recombinant protein in plant chloroplasts using a temporary immersion bioreactor.
    Michoux F; Ahmad N; McCarthy J; Nixon PJ
    Plant Biotechnol J; 2011 Jun; 9(5):575-84. PubMed ID: 21105992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Plant as bioreactor].
    Yang J; Li T; Xiong L; Pang S; Li X
    Sheng Wu Gong Cheng Xue Bao; 2009 May; 25(5):650-7. PubMed ID: 19670631
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biopharmaceuticals derived from genetically modified plants.
    Goldstein DA; Thomas JA
    QJM; 2004 Nov; 97(11):705-16. PubMed ID: 15496527
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Foreign protein production using plant cells: opportunities and challenges.
    Walmsley AM; Doran PM
    Biotechnol Adv; 2012; 30(2):385-6. PubMed ID: 21854841
    [No Abstract]   [Full Text] [Related]  

  • 14. From Neanderthal to nanobiotech: from plant potions to pharming with plant factories.
    Sourrouille C; Marshall B; Liénard D; Faye L
    Methods Mol Biol; 2009; 483():1-23. PubMed ID: 19183890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opportunities for recombinant antigen and antibody expression in transgenic plants--technology assessment.
    Schillberg S; Twyman RM; Fischer R
    Vaccine; 2005 Mar; 23(15):1764-9. PubMed ID: 15734038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transient expression systems for plant-derived biopharmaceuticals.
    Komarova TV; Baschieri S; Donini M; Marusic C; Benvenuto E; Dorokhov YL
    Expert Rev Vaccines; 2010 Aug; 9(8):859-76. PubMed ID: 20673010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Towards high-yield production of pharmaceutical proteins with plant cell suspension cultures.
    Xu J; Ge X; Dolan MC
    Biotechnol Adv; 2011; 29(3):278-99. PubMed ID: 21236330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in plant molecular farming.
    Obembe OO; Popoola JO; Leelavathi S; Reddy SV
    Biotechnol Adv; 2011; 29(2):210-22. PubMed ID: 21115109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seed-based expression systems for plant molecular farming.
    Boothe J; Nykiforuk C; Shen Y; Zaplachinski S; Szarka S; Kuhlman P; Murray E; Morck D; Moloney MM
    Plant Biotechnol J; 2010 Jun; 8(5):588-606. PubMed ID: 20500681
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recovery and purification of plant-made recombinant proteins.
    Wilken LR; Nikolov ZL
    Biotechnol Adv; 2012; 30(2):419-33. PubMed ID: 21843625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.